flag-ida plus venetoclax induction and consolidation in newly diagnosed patients with aml
Published 2 years ago • 455 plays • Length 4:57Download video MP4
Download video MP3
Similar videos
-
9:40
venetoclax combined with aml induction/consolidation therapy with flag-ida in newly diagnosed or...
-
1:54
venetoclax plus flag-ida in medically fit aml
-
3:49
venetoclax with flag-ida for aml
-
1:47
choosing between cpx-351 and flag-ida in newly diagnosed and r/r aml
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
1:02
aml19: flag-ida vs cpx-351 in patients with aml with adverse risk cytogenetics
-
2:19
cladribine ldac venetoclax alternated with azacitidine venetoclax in older patients with aml
-
1:55
first-line venetoclax plus hma vs intensive chemotherapy in older adults with idh-mutated aml
-
2:49
results from the phase iii echo trial of acalabrutinib plus br in mcl
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
2:18
the all-oral regimen of decitabine/cedazuridine, venetoclax, & gilteritinib for older pts with aml
-
1:22
select-aml-1: tamibarotene with venetoclax and azacitidine in patients with rara-positive aml
-
3:35
safety and efficacy of venetoclax-based regimens for aml
-
4:03
a phase i/ii study evaluating quizartinib plus decitabine and venetoclax in flt3-mutated aml
-
1:27
quizartinib, venetoclax, and decitabine in patients with flt3-itd aml: a phase i/ii trial
-
1:09
dec-c plus venetoclax in hr-mds and cmml: an analysis using different response criteria
-
2:25
current and emerging immune therapies in al amyloidosis: updates on hbi0101 & bispecifics
-
2:31
optimal pcr responses and survival of patients with cbf-aml treated with flag-ida or flag-go
-
1:22
centralized mrd assessment in patients with aml treated with venetoclax flai: gimema aml1718 trial
-
7:55
comparison of venetoclax-based versus non-venetoclax-based treatment regimens in aml
-
3:26
aml19 trial: flag-ida-go vs da-go in standard-risk aml and flag-ida vs cpx-351 in high-risk aml
-
2:24
what patients benefit most from the addition of venetoclax to flag-ida?